Detalles de la búsqueda
1.
Effect of platelet inhibition with cangrelor during PCI on ischemic events.
N Engl J Med
; 368(14): 1303-13, 2013 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-23473369
2.
Are adverse events following an invasive strategy in patients with non-ST-segment elevation acute coronary syndromes more frequent at US sites versus non-US sites? Analysis from the ACUITY trial.
Catheter Cardiovasc Interv
; 82(4): E365-74, 2013 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22887494
3.
Predictive value of C-reactive protein on 30-day and 1-year mortality in acute coronary syndromes: an analysis from the ACUITY trial.
J Thromb Thrombolysis
; 31(2): 154-64, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20953817
4.
Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial.
Circulation
; 119(5): 687-98, 2009 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-19171852
5.
Bivalirudin for patients with acute coronary syndromes.
N Engl J Med
; 355(21): 2203-16, 2006 Nov 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-17124018
6.
Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial.
Lancet
; 369(9565): 907-19, 2007 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-17368152
7.
Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial.
JAMA
; 298(21): 2497-506, 2007 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-18056903
8.
Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial.
JAMA
; 297(6): 591-602, 2007 Feb 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-17299194
9.
Normokinesia adjacent to left ventricular aneurysm: a differential risk for sudden cardiac death.
Eur J Heart Fail
; 4(1): 33-40, 2002 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-11812663
10.
Bleeding risk factors affecting warfarin therapy in the elderly with atrial fibrillation.
Dimens Crit Care Nurs
; 33(2): 57-63, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24496251
11.
Implications of pre-procedural TIMI flow in patients with non ST-segment elevation acute coronary syndromes undergoing percutaneous coronary revascularization: insights from the ACUITY trial.
Int J Cardiol
; 167(3): 727-32, 2013 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-22464479
12.
Quantification of the effect of clopidogrel on enzymatic infarct size related to a percutaneous coronary intervention in patients with acute coronary syndromes: insights from the CHAMPION percutaneous coronary intervention trial.
Coron Artery Dis
; 24(4): 321-7, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23442944
13.
Outcomes of patients with prior coronary artery bypass grafting and acute coronary syndromes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.
JACC Cardiovasc Interv
; 5(9): 919-26, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22995879
14.
Impact of femoral vascular closure devices and antithrombotic therapy on access site bleeding in acute coronary syndromes: The Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial.
Circ Cardiovasc Interv
; 3(1): 57-62, 2010 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20118151
15.
Comparison of catheterization laboratory initiated abciximab and eptifibatide during percutaneous coronary intervention in acute coronary syndromes (an ACUITY substudy).
Am J Cardiol
; 106(2): 180-6, 2010 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20599000
16.
A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial.
J Am Coll Cardiol
; 55(6): 543-54, 2010 Feb 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-20152559
17.
Late safety, efficacy, and cost-effectiveness of a zotarolimus-eluting stent compared with a paclitaxel-eluting stent in patients with de novo coronary lesions: 2-year follow-up from the ENDEAVOR IV trial (Randomized, Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).
JACC Cardiovasc Interv
; 2(12): 1208-18, 2009 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20129547
18.
Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.
J Am Coll Cardiol
; 54(5): 477-86, 2009 Jul 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-19628125
19.
Economic evaluation of bivalirudin with or without glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for early invasive management of acute coronary syndromes.
J Am Coll Cardiol
; 52(22): 1758-68, 2008 Nov 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-19022155
20.
Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
J Am Coll Cardiol
; 52(10): 807-14, 2008 Sep 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-18755342
Resultados
1 -
20
de 20
1
Próxima >
>>